Milestone Pharmaceuticals Capital Expenditures (CapEx) Growth & History (MIST)
Milestone Pharmaceuticals's capital expenditures (capex) was $302,000 for fiscal 2025.
View full Milestone Pharmaceuticals company overviewMilestone Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $302,000 | $269,000 | +815.15% |
| 2024 | 2024-12-31 | $33,000 | −$79,000 | −70.54% |
| 2023 | 2023-12-31 | $112,000 | −$160,000 | −58.82% |
| 2022 | 2022-12-31 | $272,000 | — | — |
| 2019 | 2019-12-31 | $413,000 | $408,000 | +8160.00% |
| 2018 | 2018-12-31 | $5,000 | — | — |
Milestone Pharmaceuticals quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $26,000 | $15,000 | +136.36% |
| Q1 2026 | 2026-03-31 | $45,000 | $39,000 | +650.00% |
| Q4 2025 | 2025-12-31 | $283,000 | — | — |
| Q3 2025 | 2025-09-30 | $2,000 | −$2,000 | −50.00% |
| Q2 2025 | 2025-06-30 | $11,000 | — | — |
| Q1 2025 | 2025-03-31 | $6,000 | — | — |
| Q3 2024 | 2024-09-30 | $4,000 | −$14,000 | −77.78% |
| Q4 2023 | 2023-12-31 | $31,000 | — | — |
| Q3 2023 | 2023-09-30 | $18,000 | −$85,000 | −82.52% |
| Q2 2023 | 2023-06-30 | $31,000 | — | — |
| Q1 2023 | 2023-03-31 | $32,000 | — | — |
| Q3 2022 | 2022-09-30 | $103,000 | — | — |
| Q3 2019 | 2019-09-30 | $294,000 | $294,000 | — |
| Q4 2018 | 2018-12-31 | $0 | — | — |
| Q3 2018 | 2018-09-30 | $0 | — | — |
| Q2 2018 | 2018-06-30 | $0 | — | — |
| Q1 2018 | 2018-03-31 | $5,000 | — | — |
Milestone Pharmaceuticals capital expenditures (capex) trends
Between the periods ended 2018-12-31 and 2025-12-31, Milestone Pharmaceuticals's capital expenditures (capex) increased from $5,000 to $302,000, a change of $297,000. The latest reported quarter, Q2 2026, shows $26,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Milestone Pharmaceuticals source filings ↗